In 1 study, patients with severe psoriasis were identified only by use of TNF‐alpha inhibitors.35 Excluding this study from the meta‐analysis did not significantly affect the outcomes (RR, 1.69; 95% CI, 1.30 to 2.19 for severe psoriasis). The gene discussed is TNF; the disease is psoriasis.